Top five aesthetics stories from the week

Two aesthetic products made waves this week with one FDA announcement and an approval. In addition, the International Society of Aesthetic Plastic Surgery released its annual statistics for 2014, which included data from over 20 million worldwide procedures.

Larger breasts increase infection, tissue expander explantation risk, despite type of acellular dermal matrix

Researchers found that higher intraoperative fill volumes, radiation therapy, obesity and larger preoperative breast size increase the risk of complications with acellular dermal matrix. Read more

Prior cosmetic breast surgery linked to complications after nipple-sparing mastectomy with inframammary fold incision

Researchers reported a higher complication rate among patients with prior cosmetic breast surgery who underwent a nipple-sparing mastectomy procedure with an inframammary fold incision in combination with implant-based reconstruction, according to a recent study. Read more

SculpSure receives FDA 510(k) marketing clearance for non-invasive lipolysis of the abdomen

Cynosure Inc. announced it has received 510(k) clearance from the FDA to market SculpSure for noninvasive lipolysis of the abdomen. Read more

FDA approves Restylane Lyft for cheek augmentation

The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of age-related midface contour deficiencies in adults aged at least 21 years, according to a press release from Galderma. Read more

ISAPS: Over 20 million cosmetic procedures performed worldwide in 2014

The International Society of Aesthetic Plastic Surgery released its annual statistics on cosmetic surgical and nonsurgical procedures for 2014, with botulinum toxin remaining the most popular procedure overall for both men and women. Read more